Literature DB >> 2944951

Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation.

E Leroy, C F Calvo, M Divine, M F Gourdin, F Baujean, M H Ben Aribia, Z Mishal, J P Vernant, J P Farcet, A Senik.   

Abstract

Fifteen patients and their respective bone marrow donors were entered in this study 1 to 5 yr after allogeneic bone marrow transplantation. Peripheral blood E rosetting (T) cells were analyzed for their phenotypic characteristics as well as for their ability to regulate Ig synthesis in the in vitro PWM system. A close relationship was found between a high proportion of T8+/HNK-1+ cells and/or T8+/HLA-DR+ cells and a strong (greater than or equal to 50%) inhibition of the antibody response. It was noteworthy that even the patients without suppressor activity had high proportions of such cells when compared with normal marrow donors. Moreover, the suppression occurred irrespective of the presence or absence of chronic GVHD. Through negative selection experiments (with MAb and complement) and through immunofluorescence cell sorting, it was shown that the suppressor cells expressed the T8+, HNK-1+, HLA-DR- phenotype. They did not carry the Leu-11, NKH1A, or NKH2 determinants, which are expressed on mature functional NK cells. When examined by electron microscopy, they exhibited a morphology of resting agranular lymphocytes. The significant increase of these suppressor cells among the BMT patients was not correlated with clinical syndromes such as chronic GVHD or opportunistic viral infections, which argues against the notion of in vivo profound immunodeficiency coexisting with these cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944951

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Suppression of in vitro immunoglobulin synthesis by CD16(Leu11a)+ CD56 (NKH1,Leu19)+non-T lineage NK cells; lack of suppression of cells from immunodeficient patients.

Authors:  T Morio; S Nonoyama; J Yata
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  CD3+ CD57+ lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients.

Authors:  B Reipert; C Scheuch; A Lukowsky; P Reinke; E Fietze; W D Döcke; G Staffa; S Czerlinksi; R Hetzer; H D Volk
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

3.  Investigation of alpha nascent polypeptide-associated complex functions in a human CD8(+) T cell ex vivo expansion model using antisense oligonucleotides.

Authors:  N Al-Shanti; C G Steward; R J Garland; A W Rowbottom
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

4.  Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.

Authors:  F Shanahan; B Leman; R Deem; A Niederlehner; M Brogan; S Targan
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

5.  Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory role.

Authors:  K Arai; S Yamamura; S Seki; T Hanyu; H E Takahashi; T Abo
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

6.  Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.

Authors:  S E McNerlan; I M Rea; H D Alexander; T C Morris
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

7.  Immunological suppression after surgery in scoliosis patients.

Authors:  N Suzuki; O Kaneko; T Nakayama; Y Fukuiya; S Kuge; Y Fujimura
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

8.  Increase in CD57 + CD16-lymphocytes in workers exposed to benzidine and beta-naphthylamine: assessment of natural killer cell subpopulations.

Authors:  T Tanigawa; S Araki; T Abo; S Sakurai
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

9.  The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity.

Authors:  J W Gratama; M Kardol; A M Naipal; J Slats; A Den Ouden; T Stijnen; J D'Amaro; T H The; J W Bruning
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

10.  Purification and partial amino acid sequence of suppressive lymphokine from a CD8+ CD57+ human T hybridoma.

Authors:  C P Quan; S Watanabe; F Vuillier; R Pires; T Matsuo; M Stanislawski; J Pillot; J P Bouvet
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.